Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Monolaurin, a monoglyceride derived from lauric acid (found in coconut oil), has garnered scientific interest for its antimicrobial properties, including activity against bacteria implicated in oral diseases such as gingivitis. Several in vitro studies have demonstrated that monolaurin can disrupt the lipid membranes of Gram-positive bacteria, including Streptococcus mutans and Porphyromonas gingivalis, both of which play roles in dental plaque formation and gingival inflammation. A few small clinical studies and pilot trials have explored the use of monolaurin-containing mouth rinses or gels, with some showing reductions in gingival inflammation and plaque scores compared to placebo. However, these studies are limited in number, often involve small sample sizes, and sometimes lack rigorous controls.

While the antimicrobial mechanism of monolaurin is well characterized in laboratory settings, robust clinical evidence supporting its effectiveness for gingivitis in humans is still emerging. No major dental or medical organizations currently recommend monolaurin as a first-line treatment for gingivitis, and it is considered an adjunct rather than a replacement for standard oral hygiene practices. The evidence supporting its use is promising but preliminary, justifying a rating of 2 out of 5. Further well-designed, large-scale clinical trials are necessary to confirm its safety and efficacy for routine use in managing gingivitis.

More about monolaurin
More about Gingivitis

Other ingredients used for Gingivitis

Other health conditions supported by monolaurin

Products containing monolaurin

Designs For Health Liposomal Cat's Claw
Designs For Health Monolaurin-Avail™